NICE has issued new guidelines on the use of Clopidogrel, recommending pharmacogenomic (PGx) testing before prescribing the medication to patients who have previously experienced a stroke or TIA.

Studies show that 30% of individuals have genetic variants that prevent Clopidogrel, a commonly prescribed medication for stroke & heart attack prevention, from working.

Some individuals have genetic variants in the CYP2C19 gene, which can have an impact on the efficacy of clopidogrel, a stroke-prevention drug.

NHS England has released a highly informative educational resource on pharmacogenomics, now available on Health Education England’s (HEE) website.

We are proud to announce that Mantara Health has been recognised as one of the top 10 precision medicine trends in 2024 in a global report by StartUs Insights.

We are delighted to share the news that we have won the 2023 PING Innovation Award for our transformative pharmacogenomics (PGx) saliva-based test, another major step in personalised medicine.

People who have had a stroke caused by a blood clot should have a DNA test to see whether they can be given a drug to help prevent more brain attacks, new draft guidelines for the NHS say.

The pilot will test patients at several NHS GP practices when they start a new statin, certain antidepressants or proton pump inhibitors to ensure they are on the right medication and not at risk of side effects.

Mantara Health are delighted to have been named the MedTech & HealthTech winner at the North East, Yorkshire, and the Humber finals of the StartUp Awards 2023 on Thursday 11th May.

The world's largest study to date on the application of pharmacogenetic information shows that adaptation of medication to DNA variants leads to 30% fewer side effects.

Health Education England provide training for healthcare practitioners in Pharmacogenomics and Stratified Healthcare.

Our partners, bio.logis digital health have compiled a comprehensive list of available literature on pharmacogenomics as part of their work on the UPGx PREPARE study.

A great summary of how fast genomics has been moving over the past few years, how quickly developments are coming and a snapshot of some of the most exciting benefits of genomics which are fast becoming a reality.

The Department of Molecular and Clinical Pharmacology at the University of Liverpool is one of the world's leading research centres in the field of pharmacogenetics and pharmacogenomics.

This article from The Telegraph explores a groundbreaking test that has the potential to revolutionise healthcare.

A recent article from The Guardian explains why experts want to use genetic testing to predict how each person responds to medicines.

This important publication from the British Pharmacological Society and the Royal College of Physicians sets out its recommendation that PGx testing be made available across the NHS.

The BBC brings attention to a major report by the British Pharmacological Society which emphasises the potential to revolutionise healthcare by precisely aligning drugs with individuals' DNA.